Pedro Luiz Serrano Uson Junior
Overview
Explore the profile of Pedro Luiz Serrano Uson Junior including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Centrone N, Serrano Uson Junior P
World J Gastrointest Oncol
. 2024 Dec;
16(12):4753-4756.
PMID: 39678805
Hepatocellular carcinoma (HCC) is a lethal disease and unfortunately, most patients will be diagnosed with unresectable/advanced stages and the overall prognosis is poor. For patients with initially unresectable HCC (uHCC),...
2.
Dias E Silva D, Borad M, Serrano Uson Junior P
World J Gastrointest Oncol
. 2024 Dec;
16(12):4766-4769.
PMID: 39678794
Newer systemic therapies for hepatocellular carcinoma (HCC) have led to growing interest in combining hepatic arterial infusion chemotherapy (HAIC) with systemic treatments. To evaluate the effectiveness and safety of HAIC...
3.
Sforzin I, Borad M, Serrano Uson Junior P
World J Gastrointest Oncol
. 2024 Nov;
16(11):4522-4527.
PMID: 39554733
Colorectal cancer (CRC) is a type of cancer that grows from polypoid lesions developing over the years. It has a high incidence of about 1.8 million new cases annually. While...
4.
Serrano Uson Junior P, Borad M
Transl Cancer Res
. 2024 Oct;
13(9):4510-4513.
PMID: 39430848
No abstract available.
5.
Serrano Uson Junior P, Nagy A, Dias I, de Rezende M, Pestana R, Bugano D, et al.
J Gastrointest Oncol
. 2024 Sep;
15(4):1820-1826.
PMID: 39279955
Background: Intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancer is becoming a common subtype of pancreatic cancer found in resected specimens. The prognostic of this subtype is still under evaluation. The...
6.
Moreno J, Serrano Uson Junior P
World J Clin Cases
. 2024 Sep;
12(25):5653-5656.
PMID: 39247732
Clear cell sarcoma (CCS) is a type of malignant tumor that can arise from tendons and aponeuroses. This malignant proliferation of cells with melanocytic lineage normally occurs in young patients,...
7.
Cassoli J, Fernandes I, Carvalho L, Fernandes M, Centrone A, Taniwaki L, et al.
Curr Issues Mol Biol
. 2024 Aug;
46(8):7976-7985.
PMID: 39194688
HER2-Low is defined as low levels of HER2 expression, based on a score of 1+ on immunohistochemical (IHC) assay or as an IHC score of 2+ and negative results on...
8.
Tustumi F, Eri R, Wende K, Nakamura E, Serrano Uson Junior P, Szor D
J Gastrointest Surg
. 2024 Jul;
28(10):1674-1681.
PMID: 39079844
Background: Vulnerable populations potentially have a worse prognosis for cancer. The present study aimed to identify individual and municipal characteristics of access to health, including education, use of health insurance,...
9.
Castro N, Moura F, Hada A, Garcia D, da Silva Victor E, Schvartsman G, et al.
Einstein (Sao Paulo)
. 2024 Jun;
22:eAO0575.
PMID: 38922219
Objective: Currently programmed cell death protein 1 (PD-1) inhibitors in combination with other therapies are being evaluated to determine their efficacy in cancer treatment. However, the effect of PD-ligand (L)...
10.
Serrano Uson Junior P, Bekaii-Saab T
J Vasc Interv Radiol
. 2024 Jan;
35(2):173-177.
PMID: 38272637
Interventional oncology (IO) is evolving rapidly. The treatment landscape of liver cancer is changing rapidly, and immunotherapy combinations have become the standard of care for most patients with advanced hepatocellular...